Cascade Financial Partners, LLC logo

Cascade Financial Partners, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Cascade Financial Partners, LLC with $872.3M in long positions as of Q3 2025, 49% allocated to ETF, and 46% concentrated in top 10 positions.

Portfolio Value
$872.3M
Top 10 Concentration
46%
Top Sector
ETF (49%)
US Exposure
99%
Market Cap Focus
N/A
Countries
5

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

ETF: 48.60%ETFHealthcare: 23.30%HealthcareTechnology: 11.50%TechnologyConsumer Cyclical: 3.30%Consumer Defensive: 3.00%Financial Services: 2.50%Communication Services: 1.80%Real Estate: 1.20%Industrials: 1.10%Energy: 0.50%Utilities: 0.20%Basic Materials: 0.10%
ETF
48.60%
Healthcare
23.30%
Technology
11.50%
Consumer Cyclical
3.30%
Consumer Defensive
3.00%
Financial Services
2.50%
Communication Services
1.80%
Real Estate
1.20%
Industrials
1.10%
Energy
0.50%
Utilities
0.20%
Basic Materials
0.10%

Industry Breakdown

55 industries across all sectors

ETF: 48.58%ETFDrug Manufacturers - General: 21.20%Drug Manufacturers - GeneralConsumer Electronics: 5.90%Semiconductors: 2.87%Beverages - Non-Alcoholic: 2.42%Software - Infrastructure: 2.24%49 more: 13.80%49 more
ETF
ETF
48.58%
Drug Manufacturers - General
Healthcare
21.20%
Consumer Electronics
Technology
5.90%
Semiconductors
Technology
2.87%
Beverages - Non-Alcoholic
Consumer Defensive
2.42%
Software - Infrastructure
Technology
2.24%
Medical - Diagnostics & Research
Healthcare
1.89%
Specialty Retail
Consumer Cyclical
1.82%
Internet Content & Information
Communication Services
1.59%
Insurance - Diversified
Financial Services
1.49%
Auto - Manufacturers
Consumer Cyclical
1.10%
REIT - Diversified
Real Estate
0.73%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 38.50%Mega Cap (> $200B)Large Cap ($10B - $200B): 8.38%Mid Cap ($2B - $10B): 0.97%Small Cap ($300M - $2B): 0.04%Micro Cap ($50M - $300M): 0.00%Nano Cap (< $50M): 0.02%N/A (ETF or Unknown): 52.08%N/A (ETF or Unknown)
Mega Cap (> $200B)
38.50%
Large Cap ($10B - $200B)
8.38%
Mid Cap ($2B - $10B)
0.97%
Small Cap ($300M - $2B)
0.04%
Micro Cap ($50M - $300M)
0.00%
Nano Cap (< $50M)
0.02%
N/A (ETF or Unknown)
52.08%

Portfolio Concentration

Top 10 Holdings %
46.37%
Top 20 Holdings %
59.12%
Top 50 Holdings %
77.55%
Top 100 Holdings %
90.76%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
99.33%
International
0.673%
Countries
5
Largest Int'l Market
Taiwan - 0.51%
United States of America
99.33% ($866.4M)
256 holdings
Taiwan
0.51% ($4.5M)
1 holdings
Ireland
0.10% ($840.2K)
2 holdings
United Kingdom
0.04% ($367.5K)
1 holdings
Canada
0.02% ($178.0K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
6 quarters
Avg. Top 20
6 quarters
Avg. All Positions
5.2 quarters
Median Holding Period
6 quarters
Persistence Rate
84.67%
Persistent Holdings Weight
96.68%
Persistent Positions
221
Longest Held
iShares Core MSCI EAFE ETF logo
iShares Core MSCI EAFE ETFIEFA - 6 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.03%
Avg. Position Weight
0.38%
Largest Position
Eli Lilly & Co. logo
Eli Lilly & Co.LLY - 20.71%
Largest Ownership Stake
FibroBiologics, Inc. Common Stock logo
FibroBiologics, Inc. Common StockFBLG - 0.71%
Avg. Ownership Stake
0.02%
Ownership Stake >5%
0
Ownership Stake >1%
0

Historical (Since Q1 2024)

Avg. New Position
0.35%
Avg. Ownership Stake
0.02%
Largest Position
Eli Lilly & Co. logo
Eli Lilly & Co.LLY - 27.86% (Q2 2024)
Largest Ownership Stake
FibroBiologics, Inc. Common Stock logo
FibroBiologics, Inc. Common StockFBLG - 0.96% (Q2 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio
1.8%
Value Traded
$15.87M
Positions Added
9
Positions Exited
10

Historical (Since Q1 2024)

Avg. Turnover Ratio
9.1%
Avg. Positions Added
42
Avg. Positions Exited
7
Highest Turnover
50.0%
Q1 2024
Lowest Turnover
1.3%
Q3 2024

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.